GASTROENTEROLOGICAL ENDOSCOPY
Online ISSN : 1884-5738
Print ISSN : 0387-1207
ISSN-L : 0387-1207
A CASE OF PNEUMATOSIS CYSTOIDES INTESTINALIS AFTER TREATMENT WITH AN α -GLUCOSIDASE INHIBITOR
Masami MIYAGAWAHidetoshi KANEMASASonoko NAKAGAWAToshiyuki NITANMasafumi MATSUMOTOKazuhiko TOKITAYoshihiro KAJITASyoji MITSUFUJITakeshi OKANOUE
Author information
JOURNAL FREE ACCESS

2006 Volume 48 Issue 3 Pages 329-333

Details
Abstract

A 65-years-old man was hospitalized for the treatment of diabetes mellitus. The patient was diagnosed as having non-insuline dependent diabetes mellitus in 1983. Since 1997, he had received 0.6mg per day of voglibose and 5.0mg per day of glibenclamide. After taking these medicine, he complained abdominal pain and diarrhea. Various examinations were performed during this hospitalization. Colonoscopy showed numerous round polypoid lesions from the ascending colon to the sigmoid colon and his disease was diagnosed as Pneumatosis cystoides intestinalis (PCI). We thought that voglibose was the cause of PCI and stopped the medication. Then his abdominal pain and diarrhea improved. When follow-up endoscopy was done at 4 month later, cystic gas-filled cysts disappeared. PCI is a rare disease forming multiple gas-filled cysts within the submucosal or subserosal layer of the intestinal wall. Recently PCI was listed as rare side effect of alpha-glucosidase inhibitors. We should consider the possibility of PCI when diabetic patients treated with alphaglucosidase inhibitors have complaints of abdominal pain and diarrhea.

Content from these authors
© Japan Gastroenterological Endoscopy Society
Previous article Next article
feedback
Top